SV Health Investors (“SV”), a leading healthcare-focused private equity firm, is pleased to announce the promotion of A.J. Rossi to Partner on the firm’s Growth-Buyout team. In this new role, A.J. will continue to lead investments and manage the SV portfolio, while helping to drive the firm’s growth initiatives across the healthcare sector.

Since joining SV Health Investors in 2022, A.J. has played a pivotal role in the firm’s successful investment strategy, focusing on identifying high-impact opportunities in the healthcare sector. With a deep understanding of market dynamics and a proven track record of working closely with portfolio companies to accelerate growth, A.J. has contributed significantly to the firm’s portfolio value creation and operational success.

“We are thrilled to announce A.J.’s promotion to Partner,” said Greg Madden, Managing Partner at SV Health Investors. “His dedication, expertise, and collaborative approach have made a lasting impact on our firm and the companies we work with. A.J. has consistently demonstrated leadership and vision in identifying and nurturing healthcare companies with transformative potential, and we look forward to seeing him continue to thrive in this expanded role.”

In addition to his investment responsibilities, A.J. will also take an active role in enhancing SV’s strategic direction, working alongside the leadership team and other Partners to further strengthen the firm’s position as a key player in the healthcare private equity space.

“I am honored to take on this new role and to continue working with such a talented and dedicated team,” said A.J. “SV Health Investors has been a catalyst for positive change in healthcare, and I look forward to helping accelerate that mission as we partner with innovative companies that are shaping the future of the industry.”

A.J. brings a wealth of experience in healthcare investing, having worked on transactions across healthcare services, outsourced medical device and pharma services, and healthcare IT verticals. Current and past healthcare Board directorships and portfolio company involvement include Robling Medical, Packaging Compliance Labs, Hightop Health, Nira Medical Group, Ria Heath, Medbio, Velosity, and HemaSource. Previously, A.J. was a Principal and co-lead of the healthcare sector at private equity firm Graham Partners. A.J. holds a bachelor’s degree from the University of Pennsylvania.

About SV Health Investors:

SV Health Investors is a private equity firm dedicated to investments in the healthcare and life sciences sector. Founded in 1993 with offices in Boston and London, SV manages approximately $2.0B across multiple investment strategies.

SV’s dedicated healthcare Growth-Buyout strategy seeks to partner with experienced management teams to accelerate the success of innovative healthcare companies across healthcare services, outsourced medtech and pharma services, medical products, and healthcare IT. SV combines decades of healthcare transaction and operating experience to drive long-term value creation and realize the triple aim of healthcare – higher quality care, accessible to more patients, at a lower cost.

For more information, visit www.svhealthinvestors.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241219443265/en/